ALLERGIC CONJUNCTIVITIS
Clinical trials for ALLERGIC CONJUNCTIVITIS explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC CONJUNCTIVITIS trials appear
Sign up with your email to follow new studies for ALLERGIC CONJUNCTIVITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drugs target itchy, red eyes from seasonal allergies
Symptom relief Recruiting nowThis study is testing two new antibody drugs, alone and together, to see if they can safely reduce the itchy and red eyes caused by birch pollen allergy. About 350 people with confirmed birch pollen eye allergies will receive either the real drugs or a placebo. The main goal is t…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Apr 02, 2026 01:57 UTC
-
New eye drops target itchy, red allergy eyes
Symptom relief Recruiting nowThis study is testing whether experimental eye drops called TL-925 can safely reduce the itching and redness caused by seasonal eye allergies. About 60 adults with a history of eye allergies will use the drops or a placebo (inactive) solution. Researchers will measure how well th…
Matched conditions: ALLERGIC CONJUNCTIVITIS
Phase: PHASE2 • Sponsor: Telios Pharma, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC